论文部分内容阅读
我们针对流行性出血热(简称流热)病毒因子及其诱导的免疫紊乱,应用抗病毒兼有免疫抑制作用的阿糖胞苷,经临床治疗观察获得了较好的疗效。本文对1981年经阿糖胞苷治疗的早期部分病例,进行了血浆中cAMP(环磷腺苷)含量的动力学观察,现报告如下。
We target epidemic hemorrhagic fever (referred to as fluid heat) virus factor and its induced immune disorders, the application of anti-viral immunosuppressive effects of cytarabine, clinically treated to obtain a better effect. In this paper, the first part of the cytarabine treated in 1981, the plasma cAMP (cyclic adenosine monophosphate) kinetics, are reported as follows.